eFFECTOR Therapeutics, Inc. EFTR
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $200.0K
- P/E
- 0.0×
Follow EFTR
| Mar '24 | Dec '23 | Sep '23 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.99 | 0.71 | 0.75 | 1.05 | |
Current Ratio |
1.03 | 0.77 | 0.82 | 1.09 | |
Net Debt/EBITDA |
0.77 | (0.12) | (0.19) | 0.73 | |
Debt/Assets |
69.72% | 94.36% | 95.75% | 71.56% | |
Debt/Equity |
22.87 | (3.35) | (4.87) | 7.47 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.61 | 0.93 | 1.03 | |
Capex/Depreciation |
0.00 | 0.76 | 0.01 | 0.55 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.78) | (2.54) | (3.14) | (4.49) | |
Capex per Share |
0.00 | (0.02) | 0.00 | (0.01) | |
Free Cash Flow per Share |
(1.78) | (2.57) | (3.14) | (4.51) | |
Cash per Share |
6.22 | 8.40 | 7.20 | 13.08 | |
Shareholders Equity per Share |
0.20 | (2.65) | (1.61) | 1.35 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.20 | (2.65) | (1.61) | 1.35 | |
Free Cash Flow |
(7.28) | (5.62) | (7.76) | (8.62) | |
Working Capital |
0.68 | (5.96) | (4.31) | 2.22 | |
Capital Expenditures |
— | (0.05) | 0.00 | (0.03) | |
Net Current Asset Value |
(0.05) | (6.50) | (4.84) | 1.66 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
— | — | 0.06 | 0.14 | |
Average Payables |
2.75 | 1.91 | 1.18 | 1.33 | |
Average Assets |
24.53 | 24.81 | 28.41 | 35.18 | |
Average Common Equity |
(1.99) | (0.95) | 3.80 | 11.10 |
Columns are period end dates